RN7SL515P

Across TCGA pan-cancer cohorts, RN7SL515P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL515P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL515P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL515P expression acts as an unfavorable survival marker, although some lineages such as GBM and HNSC show a favorable association.

MESO, BLCA, and LIHC are the cancer types where RN7SL515P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	108	view →
BLCA	OS	Tertile	III,IV	0.306	0.601	.001	63	view →
LIHC	OS	Tertile	All	0.499	0.804	<.001	57	view →
KIRC	OS	Tertile	All	0.493	0.680	.016	42	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	24	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
READ	DFS	Tertile	III,IV	0.224	0.613	.022	15	view →
GBM	OS	Tertile	All	0.698	0.289	.016	12	view →
HNSC	DFS	Tertile	All	0.566	0.283	.013	12	view →
STAD	DFS	Tertile	IV	0.151	0.528	.008	9	view →
LUAD	DFS	Tertile	All	0.691	0.324	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RN7SL515P–MESO (OS)

Open the MESO breakdown →